Search

What Is the Future of the Prostate Cancer Diagnostics Market? Growth Forecasts & Insights Global prostate cancer diagnostics market is entering a phase of accelerated expansion, driven by rising cancer prevalence, improved screening awareness, and rapid advances in diagnostic technologies. Valued at USD 14.24 billion in 2024, the market is projected to grow from USD 15.43 billion in 2025 to USD 24.78 billion by 2031, registering a strong CAGR of 8.4% during the forecast period. This growth reflects a global shift toward early detection, risk-adapted screening, and precision diagnostics that support better clinical decision-making and patient outcomes. Read the full market study https://www.24lifesciences.com/prostate-cancer-diagnostics-market-6949

The global Lyme disease testing market is entering a powerful growth phase, propelled by increasing incidence of tick-borne infections, heightened public health awareness, and rapid innovation in diagnostic technologies. Increasing investments in infectious disease screening, early detection initiatives, and healthcare infrastructure modernization are expected to fuel the market through 2035. https://www.factmr.com/report/lyme-disease-testing-market